Ocugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks Falls
OCU410 is an investigational gene therapy for geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD).
Open original sourceLoading market dashboard
OCU410 is an investigational gene therapy for geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD).
Open original source